Hyoscyamine/hexamethylenetetramine/phenyl salicylate/methylene blue/benzoic acid

Hyoscyamine/hexamethylenetetramine/phenyl salicylate/methylene blue/benzoic acid
Combination of
Hyoscyamine Antimuscarinic
Hexamethylenetetramine Bactericide/bacteriostatic
Phenyl salicylate NSAID
Methylene blue Antiseptic
Benzoic acid Acidifier
Clinical data
Trade names Methylphen, Prosed DS
AHFS/Drugs.com FDA Professional Drug Information
Routes of
administration		 By mouth
Identifiers
ChemSpider
  • none

The drug combination hyoscyamine/hexamethylenetetramine/phenyl salicylate/methylene blue/benzoic acid (trade names Methylphen, Prosed DS) is used for the treatment of urinary tract infections.[1][2]

Mechanism of action

Hyoscyamine is an antimuscarinic agent which reduces spasms of the urinary bladder's smooth muscles. Hexamethylenetetramine (also called methenamine) is hydrolyzed to formaldehyde, which acts as a bactericidal or bacteriostatic agent. Phenyl salicylate is a mild pain reliever from the class of nonsteroidal anti-inflammatory drugs (NSAIDs). Methylene blue is a weak antiseptic. Benzoic acid lowers the pH in the urine, which is necessary for hexamethylenetetramine hydrolysis,[1][2] and generates an unfavourable environment for bacteria.

Prosed EC and Prosed ED delayed-release tablets additionally contain atropine, which is closely related to hyoscyamine and has the same kind of pharmacological action.[3][4]

References

  1. 1 2 FDA Professional Drug Information on Methylphen.
  2. 1 2 RxList: Prosed DS.
  3. ↑ Micromedex Detailed Consumer Information on Prosed EC.
  4. ↑ Consumer Drug Information on Prosed ED delayed-release tablets.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.